Datu-oto, Caberan, JR.. .

HRN: 25-41-30  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2024
CEFTRIAXONE 1G (VIAL)
07/01/2024
07/08/2024
IVT
2g
Q24
UTI
Waiting Final Action 
07/02/2024
CEFTRIAXONE 1G (VIAL)
07/02/2024
07/09/2024
IV
2g
Q12
Cerebral Abscess
Waiting Final Action 
07/02/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/02/2024
07/09/2024
IV
500mg
Q6
Cerebral Abscess
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: